🔴 Medical Properties Trust is trading 6% down today after BNP Paribas Exane cut target to $2.25

Medical Properties Trust is trading at $2.05, down 5.96%, after BNP Paribas Exane’s November 3 downgrade, the clearest company-specific catalyst identified for the decline.

• The firm cut its rating to Neutral from Outperform and its price target to $2.25 from $5.00, citing tenant uncertainty, weaker performance metrics, unpaid HSA rent and an 18% Priory rent reduction.
• An October 29 report also flagged missed HSA rent and weaker normalized funds from operations, reinforcing tenant-related concerns.